← Evidence map

ArticleAging2022

SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination.

Tingting Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36566018